- Home
- FBIOP vs OVLY Comparison
FBIOP vs OVLY Comparison
Compare FBIOP & OVLY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FBIOP
- OVLY
- Stock Information
- Founded
- FBIOP N/A
- OVLY 1990
- Country
- FBIOP United States
- OVLY United States
- Employees
- FBIOP 186
- OVLY N/A
- Industry
- FBIOP Biotechnology: Pharmaceutical Preparations
- OVLY Major Banks
- Sector
- FBIOP Health Care
- OVLY Finance
- Exchange
- FBIOP Nasdaq
- OVLY Nasdaq
- Market Cap
- FBIOP N/A
- OVLY N/A
- IPO Year
- FBIOP N/A
- OVLY N/A
- Fundamental
- Price
- FBIOP $5.08
- OVLY $29.99
- Analyst Decision
- FBIOP
- OVLY
- Analyst Count
- FBIOP 0
- OVLY 0
- Target Price
- FBIOP N/A
- OVLY N/A
- AVG Volume (30 Days)
- FBIOP N/A
- OVLY 14.4K
- Earning Date
- FBIOP N/A
- OVLY 11-26-2024
- Dividend Yield
- FBIOP N/A
- OVLY 1.50%
- EPS Growth
- FBIOP N/A
- OVLY N/A
- EPS
- FBIOP N/A
- OVLY 3.01
- Revenue
- FBIOP N/A
- OVLY $77,472,000.00
- Revenue This Year
- FBIOP N/A
- OVLY N/A
- Revenue Next Year
- FBIOP N/A
- OVLY N/A
- P/E Ratio
- FBIOP N/A
- OVLY $9.79
- Revenue Growth
- FBIOP N/A
- OVLY N/A
- 52 Week Low
- FBIOP N/A
- OVLY $22.91
- 52 Week High
- FBIOP N/A
- OVLY $30.80
- Technical
- Relative Strength Index (RSI)
- FBIOP 49.96
- OVLY 62.88
- Support Level
- FBIOP $5.01
- OVLY $28.17
- Resistance Level
- FBIOP $5.86
- OVLY $30.32
- Average True Range (ATR)
- FBIOP 0.51
- OVLY 0.72
- MACD
- FBIOP -0.03
- OVLY 0.22
- Stochastic Oscillator
- FBIOP 28.99
- OVLY 69.79
About FBIOP Fortress Biotech Inc.
Fortress Biotech Inc is a biopharmaceutical company. The firm is involved in the business of acquiring, developing, and commercializing pharmaceutical and biotechnology products. Its product portfolio encompasses Qbrexza, Accutane, Amzeeq, Zilxi, Targadox, Ximino, and Exelderm. The business activities of the group are functioned through Dermatology Product Sales, and Pharmaceutical and Biotechnology Product Development. It derives the majority of its revenues from Dermatology segment. Its subsidiaries also operate in biotechnology, pharmaceutical, oncology, therapeutics sectors.